Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol/Budesonide vs Alenia in Asthma With and Without COPD
NCT04233190Phase 3Completed
- Sponsor
- Eurofarma
- Start
- Apr 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of formoterol, budesonide in asthma, sponsored by Eurofarma. Started Apr 2023; status: completed.
02
Drugs
formoterolbudesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04233190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04233190.